Incyte Corp (INCY)
57.00 x 1 72.50 x 1
Post-market by (Cboe BZX)
60.55 -0.05 (-0.08%) 03/31/25 [NASDAQ]
57.00 x 1 72.50 x 1
Post-market 60.01 -0.54 (-0.89%) 17:24 ET
for Mon, Mar 31st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Sales | 1,178,698 | 1,137,871 | 1,043,759 | 880,889 | 1,013,341 |
Cost of Goods | 88,485 | 85,993 | 76,634 | 60,956 | 69,751 |
Gross Profit | 1,090,213 | 1,051,878 | 967,125 | 819,933 | 943,590 |
Operating Expenses | 789,185 | 906,786 | 1,445,889 | 728,991 | 757,071 |
Operating Income | 301,513 | 146,085 | -478,130 | 91,898 | 187,270 |
Interest Expense | 419 | 774 | 657 | 430 | 804 |
Other Income | 12,630 | 11,213 | 89,010 | 144,691 | 84,490 |
Pre-tax Income | 313,724 | 156,524 | -389,777 | 236,159 | 270,956 |
Income Tax | 112,512 | 50,068 | 54,824 | 66,611 | 69,877 |
Net Income Continuous | 201,212 | 106,456 | -444,601 | 169,548 | 201,079 |
Net Income | $201,212 | $106,456 | $-444,601 | $169,548 | $201,079 |
EPS Basic Total Ops | 0.89 | 0.55 | -2.04 | 0.76 | 0.90 |
EPS Basic Continuous Ops | 0.89 | 0.55 | -2.04 | 0.76 | 0.90 |
EPS Diluted Total Ops | 0.90 | 0.54 | -2.04 | 0.75 | 0.89 |
EPS Diluted Continuous Ops | 0.90 | 0.54 | -2.04 | 0.75 | 0.89 |
EPS Diluted Before Non-Recurring Items | 1.09 | 0.73 | -2.03 | 0.38 | 0.82 |
EBITDA(a) | $324,246 | $168,605 | $-456,082 | $113,845 | $209,032 |